Opinion: The psychedelic revolution is leaving behind people of color
Struggling to get life-saving medications, a desperate search for bespoke treatments, and a reckoning for pharmaceutical giants
Read latest briefing →⚕️ Desk
Health, Medicine, Wellness and healthcare developments
Struggling to get life-saving medications, a desperate search for bespoke treatments, and a reckoning for pharmaceutical giants
Read latest briefing →Desk archive
Breakthroughs in disease prevention, muscle building, and cholesterol treatment contrast with concerns over pandemic preparedness and healthcare staff worries
From syphilis outbreaks to AI in pediatrics, a look at the latest healthcare developments
The healthcare sector is undergoing a series of transformations aimed at improving patient care and outcomes.
From biotech funding to global health crises, this week's top stories in healthcare
Recent studies and developments in medicine and health, from Alzheimer's treatment to disease outbreaks
Investigations and court rulings impact public health and drug development
World Health Organization investigates possible human-to-human transmission on MV Hondius
A UK-led trial finds immunotherapy effective in colon cancer, a common knee surgery is deemed
Here's the synthesized article: New Breakthroughs and Studies Shed Light on Health and Science New research and surveys are providing insights into various aspects of health and science, from cancer treatment and hearing loss
Thousands Receive Corridor Care as Scientists Seek Solutions to Aging and Gut Health
From taboo subjects to medical research controversies, women's health is in the spotlight
Hospitals adapt to doctor strikes, Ebola response requires community engagement, and global blood donations see significant increase.
Recent developments in healthcare, from pain relief for period cramps to global health concerns
Promising results from AstraZeneca and Lilly, plus a new solution for "Ozempic butt
Exploring breakthroughs in medical research and their implications for public health
Bayer sues J&J over claims that its prostate cancer treatment is more effective, citing flawed data and false advertising; lawsuit seeks damages and corrective action.
New pathway expected to spur applications for rare disease treatments
Setbacks for lung disease, puberty blockers, and cancer blood test studies
Scientists develop a simple test to predict onset of memory loss
Gilead Sciences is buying Arcellx for $7.8 billion, expanding its CAR-T therapy portfolio, while Novo Nordisk's next-gen obesity drug underperformed in a comparison study.
As the midterms approach, health care is in the spotlight, with lobbyists targeting the FDA, AI devices potentially bypassing review, and reform efforts facing an uphill battle.
Gaps in regulation and oversight leave vulnerable individuals exposed to harm
Excessive alcohol use, nicotine addiction, and chronic care experiments pose challenges to public health